Results 91 to 100 of about 464 (142)

Anti-Inflammatory Potential of Pteropodine in Rodents. [PDF]

Metabolites, 2023
Paniagua-Pérez R, Sánchez-Chapul L, Madrigal-Bujaidar E, Álvarez-González I, Madrigal-Santillán E, Cruz-Hernández L, Martínez-Canseco C, Reyes-Legorreta C, Ruiz-Rosano L, Hernández-Flores C, Valdez-Mijares R, Quintana-Armenta A.   +11 more
europepmc   +1 more source

Guía de recursos educativos para personas con enfermedades neuromusculares

, 2014
Este documento ha sido elaborado para difundir entre todas las entidades de la Federación Nacional de Enfermedades Neuromusculares (ASEM)
Pousada, Thais, Cruces Estévez, Raquel
openaire   +1 more source

Long-term clinical and radiological trajectories in ANO5-related myopathies highlight muscle MRI as a predictor of disease progression. [PDF]

J Neurol
Aragon-Gawinska K, Martí P, Azorín I, Sivera R, Aller E, Pitarch I, Benlloch C, Tárrega M, Vilar R, Díaz C, Sánchez-Roy R, Más-Estellés F, Frasquet M, Vázquez-Costa JF, Otero-Borell M, Vilchez R, Vilchez JJ, Sevilla T, Muelas N.   +18 more
europepmc   +1 more source

Correction to: Analysis of muscle magnetic resonance imaging of a large cohort of patient with VCP‑mediated disease reveals characteristic features useful for diagnosis. [PDF]

J Neurol
Esteller D, Schiava M, Verdú-Díaz J, Villar-Quiles RN, Dibowski B, Venturelli N, Laforet P, Alonso-Pérez J, Olive M, Domínguez-González C, Paradas C, Vélez B, Kostera-Pruszczyk A, Kierdaszuk B, Rodolico C, Claeys K, Pál E, Malfatti E, Souvannanorath S, Alonso-Jiménez A, de Ridder W, De Smet E, Papadimas G, Papadopoulos C, Xirou S, Luo S, Muelas N, Vilchez JJ, Ramos-Fransi A, Monforte M, Tasca G, Udd B, Palmio J, Sri S, Krause S, Schoser B, Fernández-Torrón R, López de Munain A, Pegoraro E, Farrugia ME, Vorgerd M, Manousakis G, Chanson JB, Nadaj-Pakleza A, Cetin H, Badrising U, Warman-Chardon J, Bevilacqua J, Earle N, Campero M, Díaz J, Ikenaga C, Lloyd TE, Nishino I, Nishimori Y, Saito Y, Oya Y, Takahashi Y, Nishikawa A, Sasaki R, Marini-Bettolo C, Guglieri M, Straub V, Stojkovic T, Carlier RY, Díaz-Manera J.   +65 more
europepmc   +1 more source

[Clinical and neurophysiological patterns of early presenting symptoms in acute onset chronic inflammatory demyelinating polyradiculoneuropathy]. [PDF]

Rev Neurol, 2022
Escamilla-Ramírez A, López-Hernández JC, Díaz-Martínez R, Galnares-Olalde J, Vargas-Cañas ES.   +4 more
europepmc   +1 more source

[New multidisciplinary approaches to avoid refusal of treatment in Steinert disease]. [PDF]

Rev Neurol, 2022
Ramos-Salvachúa A.
europepmc   +1 more source

Epidemiology and molecular characterization of adult genetic myopathies in a southeastern region of Spain. [PDF]

Rev Neurol
Ros-Arlanzón P, Pelegrín-Durá L, Aledo-Sala C, Moreno-Navarro L, Vaamonde-Esteban Y, Muñoz-Ambit A, Sánchez-Pérez R, Díaz-Marín C.   +7 more
europepmc   +1 more source

Model based on clinical characteristics to identify patients with neurogenic oropharyngeal dysphagia. [PDF]

Rev Cuid
Suárez-Escudero JC, González-Franco S, Franco-Sánchez I, Gómez-Ríos E, Martínez-Moreno L.   +4 more
europepmc   +1 more source

Actualización del tratamiento rehabilitador de las enfermedades neuromusculares

, 2018
In terms of neuromuscular diseases refers to a set of more than 150 different pathologies, which are sometimes also called rare diseases. Because its etiology is not currently known, it is only possible to treat it from a symptomatic point of view through rehabilitative treatment.
openaire   +1 more source

Respuesta de los autores a la carta “Síndrome de Guillain-Barré antes y durante la pandemia de COVID-19”

Gaceta Médica de México
Juan C. López-Hernández, Javier Galnares-Olalde, Edwin S. Vargas-Cañas   +2 more
doaj   +1 more source